🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to see if high-dose chemotherap...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT01538472
Treatments Being Tested
The goal of this clinical research study is to learn if adding Zevalin (ibr...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-01
Trial ID
NCT01490723
Primary Objective: * Overall Response Rate (ORR). Secondary Objectives: ...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2006-04
Trial ID
NCT00493454
Treatments Being Tested
This study will treat follicular lymphoma patients who have not received pr...
Status
Terminated
Location
Integrated Community Oncology Network
Start Date
2006-10
Trial ID
NCT00384111
Treatments Being Tested
This is a European multicenter study of 90Yttrium-Ibritumomab Tiuxetan (90Y...
Status
Unknown
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00772655
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Mayo Clinic
Start Date
2005-05-31
Trial ID
NCT00477815
Treatments Being Tested
The goal of this clinical research study is to find out if giving (Rituxan)...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00493467
Treatments Being Tested
The study involves the use of a targeted form of radiation, in addition to ...
Status
Terminated
Location
Tufts Medical Center
Start Date
2008-04
Trial ID
NCT01207765
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositum...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-07
Trial ID
NCT00416312
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as melphalan, before an autologo...
Status
Completed
Location
Kantonsspital Aarau
Start Date
2006-10
Trial ID
NCT00392691